Efforts to foster both intrinsic and extrinsic regenerative responses in heart failure have once again brought iPS cell technologies to the forefront, thanks to their flexibility in reconstructing ...

Biomedical engineers at Duke University have used induced pluripotent stem cells (iPSCs) to grow specialized blood vessel ...

In a recent study, Associate Professor Makoto Ikeya (Department of Clinical Application) and his team of researchers successfully established a method to generate jawbone-like organoids (mini-organs) ...

A collaborative research team led by Dr. Thorsten Schlaeger (Boston Children's Hospital) Emiri Nakamura and Professor Koji Eto (Department of Clinical Application) has identified microtubule (MT) ...

Induced pluripotent stem cells (iPS cells) can be created from any tissue in the human body and possess the ability to transform into a wide range of tissues. Kobe University MARUYAMA Tatsuo and his ...

A team of researchers has recently developed a nondestructive imaging and machine learning system that accurately predicts the efficiency of stem cell differentiation into muscle stem cells. The team ...

Tokyo-based K Pharma Inc. and Nikon Cell Innovation Co. on Tuesday signed a basic agreement on a new clinical trial project using induced pluripotent stem (iPS) cells to treat spinal cord injuries.

Japan's Health, Labor and Welfare Minister Kenichiro Ueno said Friday that approval will likely be given soon on the two regenerative medical products derived from induced pluripotent stem (iPS) cells ...

TOKYO (Reuters) - Japanese scientists will test the use of human-induced pluripotent stem cells (iPS) to treat spinal cord injuries, a health ministry panel that approved the research project said on ...